' 'Tis the season...for layoffs

[anonymous]

Mylan, Endo, AZ, Sanofi......
Merry Christmas

Sanofi to cut US diabetes staff
By
Lisa LaMotta

• Dec. 9, 2016
Dive Brief:

• Sanofi announced during an internal meeting on Friday morning that it is "realigning" its U.S. diabetes and cardiovascular business.
• "As a result of the new model, we did announce an approximate 20% staff reductions, including our sales force and some business support functions for this business unit," said a Sanofi spokesperson in an email.
• The realignment of its U.S. diabetes business comes as its blockbuster insulin Lantus (insulin glargine), once the company's bestselling drug, faces a new competitive threat from Eli Lilly's copycat biologic.

 

[anonymous]

Ask yourself, Would you keep all of us if it was your company? Hell no!!! These jobs are going the way of the VCRs and cassette tape players.